What do we know about the COVID-19 (coronavirus) vaccine?

Unchallenged

Novavax, a Maryland-based company working on an RNA vaccine, has been able to increase antibody response to COVID-19.

The company has reported the results of its Phase 1 trial, which reveal the levels of antibodies generated were about four times higher than those in individuals who are recovering from a COVID-19 infection.

Sources